Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William R Arnold

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Microscopy (Oxford, England)|October 31, 2021
Classifying liganded states in heterogeneous single-particle cryo-EM datasetsWilliam R Arnold, Daniel Asarnow, Yifan Cheng
Prostaglandins & Other Lipid Mediators|December 3, 2014
Endocannabinoid metabolism by cytochrome P450 monooxygenasesSusan Zelasko, William R Arnold, Aditi Das
Journal of Inorganic Biochemistry|April 25, 2018
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2William R Arnold, Austin T Weigle, Aditi Das
ACS Chemical Biology|March 24, 2025
The Hunt for the Putative Epoxyeicosatrienoic Acid ReceptorWilliam R Arnold, Sona Jain, Vidya Sinha, et al.
Biochemistry|December 21, 2016
Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 EpoxygenaseWilliam R Arnold, Javier L Baylon, Emad Tajkhorshid, et al.
Biochemistry|December 5, 2017
Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by DoxorubicinWilliam R Arnold, Javier L Baylon, Emad Tajkhorshid, et al.
International Journal of Molecular Sciences|September 22, 2019
Polymorphisms of CYP2C8 Alter First-Electron Transfer Kinetics and Increase Catalytic UncouplingWilliam R Arnold, Susan Zelasko, Daryl D Meling, et al.
Acta Crystallographica. Section E, Structure Reports Online|June 1, 2013
{2,2'-[N,N'-Bis(pyridin-2-ylmeth-yl)propane-1,3-diyldi(nitrilo)]di-acetato}-cobalt(III) hexa-fluoridophosphate aceto-nitrile 0.064-solvateCraig C McLauchlan, Daniel S Kissel, William R Arnold, et al.
Biochemistry|October 5, 2018
Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 EpoxygenaseLauren N Carnevale, Andres S Arango, William R Arnold, et al.
Nature Structural & Molecular Biology|May 2, 2024
Structural basis of TRPV1 modulation by endogenous bioactive lipidsWilliam R Arnold, Adamo Mancino, Frank R Moss, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Microscopy (Oxford, England)|October 31, 2021
Classifying liganded states in heterogeneous single-particle cryo-EM datasetsWilliam R Arnold, Daniel Asarnow, Yifan Cheng
Prostaglandins & Other Lipid Mediators|December 3, 2014
Endocannabinoid metabolism by cytochrome P450 monooxygenasesSusan Zelasko, William R Arnold, Aditi Das
Journal of Inorganic Biochemistry|April 25, 2018
Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2William R Arnold, Austin T Weigle, Aditi Das
ACS Chemical Biology|March 24, 2025
The Hunt for the Putative Epoxyeicosatrienoic Acid ReceptorWilliam R Arnold, Sona Jain, Vidya Sinha, et al.
Biochemistry|December 21, 2016
Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 EpoxygenaseWilliam R Arnold, Javier L Baylon, Emad Tajkhorshid, et al.
Biochemistry|December 5, 2017
Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by DoxorubicinWilliam R Arnold, Javier L Baylon, Emad Tajkhorshid, et al.
International Journal of Molecular Sciences|September 22, 2019
Polymorphisms of CYP2C8 Alter First-Electron Transfer Kinetics and Increase Catalytic UncouplingWilliam R Arnold, Susan Zelasko, Daryl D Meling, et al.
Acta Crystallographica. Section E, Structure Reports Online|June 1, 2013
{2,2'-[N,N'-Bis(pyridin-2-ylmeth-yl)propane-1,3-diyldi(nitrilo)]di-acetato}-cobalt(III) hexa-fluoridophosphate aceto-nitrile 0.064-solvateCraig C McLauchlan, Daniel S Kissel, William R Arnold, et al.
Biochemistry|October 5, 2018
Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 EpoxygenaseLauren N Carnevale, Andres S Arango, William R Arnold, et al.
Nature Structural & Molecular Biology|May 2, 2024
Structural basis of TRPV1 modulation by endogenous bioactive lipidsWilliam R Arnold, Adamo Mancino, Frank R Moss, et al.
Pageof 2